CMND — Clearmind Medicine Share News
0.000.00%
Last trade - 00:00Brief: Clearmind Medicine Receives Notice Of Allowance For United States Patent Covering Binge Behavior
Brief: Clearmind Medicine Launches First U.S. Clinical Site For Its FDA-Approved Clinical Trial To Combat Alcoholism
developed treatment to overcome cocaine addiction
Brief: Scisparc-Clearmind Medicine Collaboration Announces The Publication Of European Patent Application For Binge Behavior Psychedelic Combination Treatment
Brief: Scisparc Announces US Patent Application For Treating Metabolic Syndrome And Weight Loss
Brief: Clearmind Medicine Announces Submission Of US Patent Application For Treating Metabolic Syndrome And Weight-Loss
Brief: Clearmind Medicine Secured Exclusive Global Rights To Innovative Psychedelic Compounds For PTSD Treatment
Brief: Clearmind Medicine Announces Exclusive Licensing Agreement For Generation 3.0 Psychedelic Compounds For The Treatment Of Mental Disorders
Brief: Clearmind Medicine Files U.S. Patent Application For Psychedelic-Based Treatment For Eating Disorders
Brief: Clearmind Medicine Announces International Patent Application For Preventing, Treating Depression